Together Pharma

Together Pharma Debt

The Debt of Together Pharma (TGTR.TA) as of Oct 8, 2026 is 63.66 M ILS. In the previous year, Debt was 97.65 M ILS — a change of -34.81% (lower).

Debt

63.66 MILS

YoY

-34.81%

Last updated:

In 2024, Together Pharma's total debt was 63.66 M ILS, a -34.81% change from the 97.65 M ILS total debt recorded in the previous year.

The Together Pharma Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
746,000.00 ILS
Jan 1, 2018
44.50 M ILS
Jan 1, 2019
50.23 M ILS
Jan 1, 2020
88.90 M ILS
Jan 1, 2021
67.61 M ILS
Jan 1, 2022
94.92 M ILS
Jan 1, 2023
97.65 M ILS
Jan 1, 2024
63.66 M ILS
The Together Pharma Debt history
YEARDebtYoY
63.66 MILS-34.81%
97.65 MILS+2.88%
94.92 MILS+40.40%
67.61 MILS-23.96%
88.90 MILS+77.00%
50.23 MILS+12.88%
44.50 MILS+5,864.48%
746,000.00ILS-85.71%
5.22 MILS-4.17%
5.45 MILS-5.96%
5.79 MILS—
Access this data via the Eulerpool API
Get Free API Key

Together Pharma Stock analysis

What does Together Pharma do? Together Pharma is one of the most popular companies on Eulerpool.

Debt Details

Understanding Together Pharma's Debt Structure

Together Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Together Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Together Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Together Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Together Pharma stock

Debt of Together Pharma is 63.66 M ILS in 2024.

Debt of Together Pharma changed from 97.65 M ILS to 63.66 M ILS, representing a -34.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Together Pharma since 2006 – with annual values, charts, and detailed analysis.

Debt's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Together Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Together Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Together Pharma